Table 1 Effects of osilodrostat, metyrapone, and ketoconazole on the steroid profile in human adrenocortical cells
Table 2 Effects of osilodrostat, metyrapone, and ketoconazole on the steroid profile in two primary human adrenocortical cell cultures

Figure 1 Effects of osilodrostat, metyrapone, and ketoconazole on basal cortisol production in primary human adrenocortical carcinoma cultures
Figure 2 Effects of osilodrostat on cell amount and ACTH secretion corrected for cell amount in mouse pituitary AtT20 cells and in two primary human corticotroph pituitary adenoma cultures

hdl.handle.net/1765/115683
Journal of Clinical Endocrinology and Metabolism
Erasmus MC: University Medical Center Rotterdam

Creemers, S. (2019). Supplementary material belonging to: Osilodrostat is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing’s Syndrome: an in Vitro Study. Journal of Clinical Endocrinology and Metabolism. Retrieved from http://hdl.handle.net/1765/115683